US Stock MarketDetailed Quotes

Grace Therapeutics (GRCE)

Watchlist
  • 3.650
  • +0.010+0.27%
Close Jan 16 16:00 ET
  • 3.540
  • -0.110-3.01%
Post 17:05 ET
56.48MMarket Cap-6.89P/E (TTM)

Grace Therapeutics (GRCE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.86%-3.14M
49.92%-1.8M
-20.85%-14.9M
-41.48%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.50%-12.33M
37.22%-2.09M
49.17%-1.89M
Net income from continuing operations
72.64%-939K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
Operating gains losses
-295.29%-1.43M
134.91%487K
-218.76%-3.22M
-355.37%-2.64M
1,034.92%1.18M
---361K
---1.4M
7,864.71%2.71M
1,334.72%1.03M
-647.83%-126K
Depreciation and amortization
--0
100.00%2K
-36.36%7K
100.00%2K
100.00%2K
0.00%2K
-85.71%1K
-91.13%11K
-87.50%1K
-90.00%1K
Deferred tax
--0
--0
-74.62%-3.2M
-14.51%-1.02M
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
24.09%-208K
Other non cash items
----
----
----
----
----
----
--1K
----
----
----
Change In working capital
-586.63%-983K
-14.54%770K
126.72%342K
-109.38%-66K
-237.35%-695K
143.53%202K
144.47%901K
-807.18%-1.28M
99.43%704K
1,545.71%506K
-Change in receivables
--0
-67.48%106K
645.00%596K
-26.16%175K
193.44%114K
---19K
1,031.43%326K
126.49%80K
797.06%237K
-234.07%-122K
-Change in prepaid assets
-42.07%84K
86.14%-47K
-153.97%-170K
-75.38%130K
-145.49%-106K
74.70%145K
35.92%-339K
337.50%315K
16.30%528K
-27.64%233K
-Change in payables and accrued expense
-1,503.95%-1.07M
-22.21%711K
94.92%-84K
-508.20%-371K
-277.97%-703K
114.15%76K
163.08%914K
-501.95%-1.65M
8.96%-61K
188.17%395K
-Change in other current assets
----
----
--0
--0
--0
--0
--0
---23K
--0
--0
Cash from discontinued investing activities
Operating cash flow
25.86%-3.14M
49.92%-1.8M
-20.85%-14.9M
-41.48%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.50%-12.33M
37.22%-2.09M
49.17%-1.89M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
100.23%15K
0
-15K
-99.21%104K
31.17%6.55M
-31.05%-6.55M
Net PPE purchase and sale
----
----
--0
--0
--0
----
----
623.53%89K
-162.50%-21K
--0
Net investment purchase and sale
--0
--0
--0
--0
100.23%15K
--0
---15K
-99.89%15K
31.38%6.57M
-31.05%-6.55M
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
100.23%15K
--0
---15K
-99.21%104K
31.17%6.55M
-31.05%-6.55M
Financing cash flow
Cash flow from continuing financing activities
0
-327K
90.68%14.03M
14.03M
0
0
0
2,320.72%7.36M
0
0
Net common stock issuance
----
----
99.99%15M
9,158.64%15M
--0
----
----
2,367.11%7.5M
--162K
--0
Proceeds from stock option exercised by employees
----
----
--0
--0
--0
----
----
--21K
--0
--0
Net other financing activities
--0
---327K
-496.91%-967K
----
----
----
----
---162K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
---327K
90.68%14.03M
--14.03M
--0
--0
--0
2,320.72%7.36M
--0
--0
Net cash flow
Beginning cash position
3.15%20.01M
-3.79%22.13M
-17.47%23.01M
-40.39%11.06M
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-8.12%27.88M
-29.33%18.55M
-22.72%26.99M
Current changes in cash
25.86%-3.14M
41.07%-2.13M
82.09%-872K
148.39%11.08M
51.46%-4.1M
-179.14%-4.24M
42.13%-3.61M
-98.29%-4.87M
167.71%4.46M
3.18%-8.45M
Effect of exchange rate changes
----
----
----
----
----
----
--0
--0
----
----
End cash Position
11.26%16.86M
3.15%20.01M
-3.79%22.13M
-3.79%22.13M
-40.39%11.06M
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-17.47%23.01M
-29.33%18.55M
Free cash flow
25.86%-3.14M
49.92%-1.8M
-20.63%-14.9M
-40.00%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.44%-12.36M
36.71%-2.11M
49.17%-1.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.86%-3.14M49.92%-1.8M-20.85%-14.9M-41.48%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.50%-12.33M37.22%-2.09M49.17%-1.89M
Net income from continuing operations 72.64%-939K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M
Operating gains losses -295.29%-1.43M134.91%487K-218.76%-3.22M-355.37%-2.64M1,034.92%1.18M---361K---1.4M7,864.71%2.71M1,334.72%1.03M-647.83%-126K
Depreciation and amortization --0100.00%2K-36.36%7K100.00%2K100.00%2K0.00%2K-85.71%1K-91.13%11K-87.50%1K-90.00%1K
Deferred tax --0--0-74.62%-3.2M-14.51%-1.02M-190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K24.09%-208K
Other non cash items --------------------------1K------------
Change In working capital -586.63%-983K-14.54%770K126.72%342K-109.38%-66K-237.35%-695K143.53%202K144.47%901K-807.18%-1.28M99.43%704K1,545.71%506K
-Change in receivables --0-67.48%106K645.00%596K-26.16%175K193.44%114K---19K1,031.43%326K126.49%80K797.06%237K-234.07%-122K
-Change in prepaid assets -42.07%84K86.14%-47K-153.97%-170K-75.38%130K-145.49%-106K74.70%145K35.92%-339K337.50%315K16.30%528K-27.64%233K
-Change in payables and accrued expense -1,503.95%-1.07M-22.21%711K94.92%-84K-508.20%-371K-277.97%-703K114.15%76K163.08%914K-501.95%-1.65M8.96%-61K188.17%395K
-Change in other current assets ----------0--0--0--0--0---23K--0--0
Cash from discontinued investing activities
Operating cash flow 25.86%-3.14M49.92%-1.8M-20.85%-14.9M-41.48%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.50%-12.33M37.22%-2.09M49.17%-1.89M
Investing cash flow
Cash flow from continuing investing activities 0000100.23%15K0-15K-99.21%104K31.17%6.55M-31.05%-6.55M
Net PPE purchase and sale ----------0--0--0--------623.53%89K-162.50%-21K--0
Net investment purchase and sale --0--0--0--0100.23%15K--0---15K-99.89%15K31.38%6.57M-31.05%-6.55M
Cash from discontinued investing activities
Investing cash flow --0--0--0--0100.23%15K--0---15K-99.21%104K31.17%6.55M-31.05%-6.55M
Financing cash flow
Cash flow from continuing financing activities 0-327K90.68%14.03M14.03M0002,320.72%7.36M00
Net common stock issuance --------99.99%15M9,158.64%15M--0--------2,367.11%7.5M--162K--0
Proceeds from stock option exercised by employees ----------0--0--0----------21K--0--0
Net other financing activities --0---327K-496.91%-967K-------------------162K--------
Cash from discontinued financing activities
Financing cash flow --0---327K90.68%14.03M--14.03M--0--0--02,320.72%7.36M--0--0
Net cash flow
Beginning cash position 3.15%20.01M-3.79%22.13M-17.47%23.01M-40.39%11.06M-43.85%15.16M-10.35%19.39M-17.47%23.01M-8.12%27.88M-29.33%18.55M-22.72%26.99M
Current changes in cash 25.86%-3.14M41.07%-2.13M82.09%-872K148.39%11.08M51.46%-4.1M-179.14%-4.24M42.13%-3.61M-98.29%-4.87M167.71%4.46M3.18%-8.45M
Effect of exchange rate changes --------------------------0--0--------
End cash Position 11.26%16.86M3.15%20.01M-3.79%22.13M-3.79%22.13M-40.39%11.06M-43.85%15.16M-10.35%19.39M-17.47%23.01M-17.47%23.01M-29.33%18.55M
Free cash flow 25.86%-3.14M49.92%-1.8M-20.63%-14.9M-40.00%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.44%-12.36M36.71%-2.11M49.17%-1.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More